Content » Vol 96, Issue 3

Short communication

Bullous Delayed Pressure Urticaria Responding to Omalizumab

Supplementary content
Figure S1
Licenses
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.